Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets

It remains unknown as to whether the use of new-generation drug-eluting stent (NG-DES) in patients with ST-elevation myocardial infarction (STEMI) who receive an undefined duration of dual antiplatelet therapy (DAPT) reduces the risk of hospitalization for heart failure (HHF). In this population-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Li-Nien, Chen, Chun-Chao, Chang, Ya-Hui, Yu, Fa-Chang, Tsai, Chen-Ting, Liu, Hung-Yi, Yeh, Hung-I, Lin, Chao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950168/
https://www.ncbi.nlm.nih.gov/pubmed/35330369
http://dx.doi.org/10.3390/jpm12030369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950168/
https://www.ncbi.nlm.nih.gov/pubmed/35330369
http://dx.doi.org/10.3390/jpm12030369

Ejemplares similares